Making Vaccines Accessible

Despite the challenges and high cost of development, vaccine innovation is at an all-time high, as new approaches aim to improve global access.
Nov 15, 2017
Volume 2017 eBook, Issue 3, pg 4-10

Vaccines have had a tremendous impact on human quality of life, increasing life expectancies by eradicating deadly diseases.  The cost of developing and manufacturing vaccines remains extremely high, however. Given unprofitable prices, improving access to vaccines has been a major challenge.  Despite these problems, innovation is reaching a new level, while new approaches to manufacturing and distribution involving non-government organizations and contract manufacturers offshore have helped improve access.  This article touches on some of the innovations, and the types of business models that have made them possible, and includes an interview with the director of the Sabin Institute.

Read this article from Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017 eBook.

View other articles in Pharmaceutical Technology and BioPharm International’s 2017 Vaccine Development and Manufacturing 2017 eBook. 

Article Details

Pharmaceutical Technology and BioPharm International
eBook: Vaccine Development and Manufacturing 2017
November 2017
Pages: 4–10

Citation

When referring to this article, please cite it as A. Shanley, "Making Vaccines Accessible," Pharmaceutical Technology and BioPharm International Vaccine Development and Manufacturing 2017 eBook (November 2017).

native1_300x100
lorem ipsum